PlainRecalls
FDA Drug Moderate Class II Completed

Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80

Reported: May 25, 2022 Initiated: April 5, 2022 #D-0883-2022

Product Description

Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80

Reason for Recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Details

Recalling Firm
Cardinal Health Inc.
Units Affected
1 box
Distribution
NM only
Location
Dublin, OH

Frequently Asked Questions

What product was recalled?
Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80. Recalled by Cardinal Health Inc.. Units affected: 1 box.
Why was this product recalled?
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 25, 2022. Severity: Moderate. Recall number: D-0883-2022.